Bayer | BAYN - Assets

Stock Price
37.61
Daily Change
-0.11 -0.28%
Monthly
-9.08%
Yearly
64.11%
Q2 Forecast
36.73

Bayer reported EUR107.94B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Air Liquide EUR 51.91B 2.58B Dec/2025
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Alcon AG USD 31.62B 64M Mar/2026
Amarin USD 645.76M 25.01M Mar/2026
Arkema EUR 14.22B 24.3M Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Corteva USD 42.72B 128M Mar/2026
Covestro EUR 13.47B 245M Dec/2025
Essilor EUR 63.9B 1.97B Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Henkel EUR 32.53B 258M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.83B 362M Dec/2025
Linde USD 86.82B 824M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Nutrien USD 53.92B 1.62B Mar/2026
Philips EUR 27.27B 322M Mar/2026
PPG Industries USD 22.15B 52M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
SAP EUR 73.46B 3.1B Mar/2026
Solvay EUR 6.2B 45M Mar/2026
UCB EUR 18.16B 971M Dec/2025
Umicore EUR 9.46B 865.5M Dec/2025
Vinci EUR 133.06B 2.62B Dec/2025